369 related articles for article (PubMed ID: 10933050)
21. Differential cytotoxicity and bystander effect of the rabbit cytochrome P450 4B1 enzyme gene by two different prodrugs: implications for pharmacogene therapy.
Frank S; Steffens S; Fischer U; Tlolko A; Rainov NG; Kramm CM
Cancer Gene Ther; 2002 Feb; 9(2):178-88. PubMed ID: 11857036
[TBL] [Abstract][Full Text] [Related]
22. Generation of fusion genes carrying drug resistance, green fluorescent protein, and herpes simplex virus thymidine kinase genes in a single cistron.
Oh SC; Nam SY; Kwon HC; Kim CM; Seo JS; Seong RH; Jang YJ; Chung YH; Chung HY
Mol Cells; 2001 Apr; 11(2):192-7. PubMed ID: 11355700
[TBL] [Abstract][Full Text] [Related]
23. Abnormal expression of only the CD34 part of a transgenic CD34/herpes simplex virus-thymidine kinase fusion protein is associated with ganciclovir resistance.
Bennour E; Ferrand C; Rémy-Martin JP; Certoux JM; Gorke S; Qasim W; Gaspar HB; Baumert T; Duperrier A; Deschamps M; Fehse B; Tiberghien P; Robinet E
Hum Gene Ther; 2008 Jul; 19(7):699-709. PubMed ID: 18557699
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo characterization of a dual-function green fluorescent protein--HSV1-thymidine kinase reporter gene driven by the human elongation factor 1 alpha promoter.
Luker GD; Luker KE; Sharma V; Pica CM; Dahlheimer JL; Ocheskey JA; Fahrner TJ; Milbrandt J; Piwnica-Worms D
Mol Imaging; 2002; 1(2):65-73. PubMed ID: 12920846
[TBL] [Abstract][Full Text] [Related]
25. Intracellular localization of Herpes simplex virus type 1 thymidine kinase fused to different fluorescent proteins depends on choice of fluorescent tag.
Söling A; Simm A; Rainov N
FEBS Lett; 2002 Sep; 527(1-3):153-8. PubMed ID: 12220652
[TBL] [Abstract][Full Text] [Related]
26. Imaging of gene expression in live pancreatic islet cell lines using dual-isotope SPECT.
Tai JH; Nguyen B; Wells RG; Kovacs MS; McGirr R; Prato FS; Morgan TG; Dhanvantari S
J Nucl Med; 2008 Jan; 49(1):94-102. PubMed ID: 18077534
[TBL] [Abstract][Full Text] [Related]
27. Non-small cell lung cancer as a target disease for herpes simplex type 1 thymidine kinase-ganciclovir gene therapy.
Määttä AM; Tenhunen A; Pasanen T; Meriläinen O; Pellinen R; Mäkinen K; Alhava E; Wahlfors J
Int J Oncol; 2004 Apr; 24(4):943-9. PubMed ID: 15010834
[TBL] [Abstract][Full Text] [Related]
28. VP22 does not significantly enhance enzyme prodrug cancer gene therapy as a part of a VP22-HSVTk-GFP triple fusion construct.
Hakkarainen T; Wahlfors T; Meriläinen O; Loimas S; Hemminki A; Wahlfors J
J Gene Med; 2005 Jul; 7(7):898-907. PubMed ID: 15759279
[TBL] [Abstract][Full Text] [Related]
29. Imaging the expression of transfected genes in vivo.
Tjuvajev JG; Stockhammer G; Desai R; Uehara H; Watanabe K; Gansbacher B; Blasberg RG
Cancer Res; 1995 Dec; 55(24):6126-32. PubMed ID: 8521403
[TBL] [Abstract][Full Text] [Related]
30. Cytoplasmically retargeted HSV1-tk/GFP reporter gene mutants for optimization of noninvasive molecular-genetic imaging.
Ponomarev V; Doubrovin M; Serganova I; Beresten T; Vider J; Shavrin A; Ageyeva L; Balatoni J; Blasberg R; Tjuvajev JG
Neoplasia; 2003; 5(3):245-54. PubMed ID: 12869307
[TBL] [Abstract][Full Text] [Related]
31. Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas.
Jacobs A; Voges J; Reszka R; Lercher M; Gossmann A; Kracht L; Kaestle C; Wagner R; Wienhard K; Heiss WD
Lancet; 2001 Sep; 358(9283):727-9. PubMed ID: 11551583
[TBL] [Abstract][Full Text] [Related]
32. Differential intracellular compartmentalization of herpetic thymidine kinases (TKs) in TK gene-transfected tumor cells: molecular characterization of the nuclear localization signal of herpes simplex virus type 1 TK.
Degrève B; Johansson M; De Clercq E; Karlsson A; Balzarini J
J Virol; 1998 Dec; 72(12):9535-43. PubMed ID: 9811686
[TBL] [Abstract][Full Text] [Related]
33. Transduction of human pancreatic tumor cells with vesicular stomatitis virus G-pseudotyped retroviral vectors containing a herpes simplex virus thymidine kinase mutant gene enhances bystander effects and sensitivity to ganciclovir.
Howard BD; Boenicke L; Schniewind B; Henne-Bruns D; Kalthoff H
Cancer Gene Ther; 2000 Jun; 7(6):927-38. PubMed ID: 10880025
[TBL] [Abstract][Full Text] [Related]
34. In vivo imaging of herpes simplex virus type 1 thymidine kinase gene expression: early kinetics of radiolabelled FIAU.
Haubner R; Avril N; Hantzopoulos PA; Gansbacher B; Schwaiger M
Eur J Nucl Med; 2000 Mar; 27(3):283-91. PubMed ID: 10774880
[TBL] [Abstract][Full Text] [Related]
35. Herpes simplex virus thymidine kinase-green fluorescent protein fusion gene: new tool for gene transfer studies and gene therapy.
Loimas S; Wahlfors J; Jänne J
Biotechniques; 1998 Apr; 24(4):614-8. PubMed ID: 9564534
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic efficacy of the suicide gene driven by the promoter of vascular endothelial growth factor gene against hypoxic tumor cells.
Koshikawa N; Takenaga K; Tagawa M; Sakiyama S
Cancer Res; 2000 Jun; 60(11):2936-41. PubMed ID: 10850440
[TBL] [Abstract][Full Text] [Related]
37. Effect of herpes simplex virus thymidine kinase expression levels on ganciclovir-mediated cytotoxicity and the "bystander effect".
Chen CY; Chang YN; Ryan P; Linscott M; McGarrity GJ; Chiang YL
Hum Gene Ther; 1995 Nov; 6(11):1467-76. PubMed ID: 8573619
[TBL] [Abstract][Full Text] [Related]
38. Cells exposed to antifolates show increased cellular levels of proteins fused to dihydrofolate reductase: a method to modulate gene expression.
Mayer-Kuckuk P; Banerjee D; Malhotra S; Doubrovin M; Iwamoto M; Akhurst T; Balatoni J; Bornmann W; Finn R; Larson S; Fong Y; Gelovani Tjuvajev J; Blasberg R; Bertino JR
Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3400-5. PubMed ID: 11891321
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
